Product category:
Contract research
News Release from: Pharmaceutical Profiles
Edited by the Laboratorytalk Editorial
Team on 17 March 2003
Volunteer recruitment manager appointed
George Singleton will manage and oversee the development of the company's recruitment effort for volunteers who take part in the early phase clinical trials
Early clinical phase drug development company Pharmaceutical Profiles has strengthened its key volunteer recruitment programme with the appointment of Georgina (George) Singleton as volunteer recruitment manager She will manage and oversee the development of the company's recruitment effort for volunteers who take part in the early phase clinical trials carried out on behalf of many of the world's largest pharmaceutical and biotechnology companies
This article was originally published on Laboratorytalk on 30 May 2003 at 8.00am (UK)
Related stories
Human absorption studies webcast
The role of absorption studies in humans is to be examined by one of the pharmaceutical industry's leading authorities in oral drug delivery in a web-based seminar
Added value for pharmacokinetic studies
Service designed to maximise the data obtained from 'standard' clinical studies in healthy volunteers has been launched by an early phase drug development specialist
This will include planning, implementing and project managing promotional and advertising campaigns designed to attract new volunteers.
George will manage a screening team of six, which will include three nurses and three recruitment coordinators.
This team is directly responsible for recruiting new volunteers for Pharmaceutical Profiles panel and coordinating the involvement of the volunteers in medical studies.
Almost 10,000 healthy volunteers have worked with Pharmaceutical Profiles over its 13-year history.
Having graduated from Lancaster University, George became a recruitment consultant.
She joined Pharmaceutical Profiles in March 2000 as a recruitment coordinator.
Now, in addition to her new role, she has also returned part-time to education and is studying at weekends for a postgraduate diploma in management studies that she hopes to convert into an MBA in 2004.
Looking forward to the challenges of managing the team and the volunteer panel, she explained: "It is a challenge to maintain a panel of the size of Pharmaceutical Profiles's because there is an ever-increasing demand for healthy volunteers and frequently for specific types of people to take part in studies, such as asthma sufferers or healthy non-smokers of a particular age," she explained.
• Pharmaceutical Profiles: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
